The Urban Monk podcast with Dr Pedram Shojai. https://www.theurbanmonk.com/ Health, wellness, and personal development media in a new steaming service that's designed to help you live your best life. Try this free course from The Urban Monk https://theurbanmonk.com/reboot Pedram Shojai is the Urban Monk. He is a Doctor of Oriental Medicine, a Taoist Priest, a Qi Gong Master, film maker, author, and Kung Fu world traveler. He invites you to join in the conversation exploring what it means to live with balance in the 21st century. Meet Dr Dale Bredesen Dale Bredesen, MD, received his undergraduate degree from Caltech and his medical degree from Duke University. He served as resident and chief resident in neurology at the University of California, San Francisco (UCSF) and as postdoctoral fellow in the laboratory of Nobel Laureate Professor Stanley Prusiner. He was a faculty member at University of California, Los Angeles (UCLA) from 1989 to 1994 and was then recruited by the Burnham Institute to direct the Program on Aging. In 1998, he became the founding president and CEO of the Buck Institute for Research on Aging and adjunct professor at UCSF. From 2013 to 2023, he returned to UCLA as a professor and director of the Easton Center for Alzheimer's Disease Research. He is currently Senior Director of the world's first precision medicine program for neurodegenerative diseases, which is at the Pacific Neuroscience Institute. The Bredesen Laboratory studies basic mechanisms underlying the neurodegenerative process and the translation of this knowledge into effective therapeutics for Alzheimer's disease and other neurodegenerative conditions, which has led to the publication of over 200 research papers. He was the principal investigator for the Alzheimer's Disease Research Center at UCLA. He established the ADDN (Alzheimer's Drug Development Network) with Dr. Varghese John in 2008, leading to the identification of new classes of therapeutics for Alzheimer's disease. His group has developed a new approach to the treatment of Alzheimer's disease, the MEND protocol, and this approach has led to the first description of a reversal of symptoms in patients with mild cognitive impairment (MCI) and early Alzheimer's disease. Dr. Bredesen is the author of two New York Times bestsellers: The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline and The End of Alzheimer's Program.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related